Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Optimizing Cell-Based Assays with Zolmitriptan (SKU B2261)
2026-04-30
This article addresses key experimental scenarios in cell viability and serotonin receptor pharmacology, demonstrating how Zolmitriptan (SKU B2261) from APExBIO supports reproducible, high-integrity results. Researchers will find evidence-based guidance on solubility, assay compatibility, and vendor selection, anchored by current literature and validated protocols.
-
2X Taq PCR Master Mix: Streamlining PCR for Genotyping & Clo
2026-04-29
The 2X Taq PCR Master Mix (with dye) accelerates DNA amplification workflows with direct gel loading, enabling robust genotyping, cloning, and sequence analysis. Its streamlined formulation reduces handling errors and enhances reproducibility for both routine and advanced molecular biology applications.
-
TRIM66: Epigenetic Control of Monogenic Olfactory Receptor E
2026-04-29
This study identifies TRIM66 as a pivotal epigenetic repressor that enforces the monogenic and monoallelic expression of olfactory receptor genes in sensory neurons. By detailing TRIM66's mechanism—direct repression of receptor enhancers—the work fills a long-standing mechanistic gap and highlights new avenues for dissecting transcriptional singularity in complex gene families.
-
GPC3-HSP70 mRNA Nanovaccine Plus PD-L1 Blockade in HCC Immun
2026-04-28
This study presents a novel mRNA nanovaccine targeting GPC3, fused with HSP70, for hepatocellular carcinoma (HCC), demonstrating enhanced antigen-specific T-cell responses and synergistic antitumor activity when combined with anti-PD-L1 therapy. The findings provide mechanistic insight into mRNA vaccine design and highlight translational opportunities for improving immunotherapy efficacy in solid tumors.
-
Sulfaphenazole Restores Perfusion and Reduces Skin Injury Se
2026-04-28
The referenced study demonstrates that sulfaphenazole, a selective CYP2C9 inhibitor, can significantly reduce the severity of thermal and pressure-induced skin injuries by rapidly restoring tissue perfusion in a mouse model. These findings highlight sulfaphenazole’s multifaceted mechanism—combining vascular protection and inflammation reduction—offering a promising direction for vascular endothelial function research and ischemic injury management.
-
Aging Lens Epithelium: Ferroptosis Susceptibility in Catarac
2026-04-27
Wei et al. demonstrate that aging lens epithelial cells (LECs) are highly susceptible to ferroptosis, an iron-dependent, non-apoptotic cell death mechanism, revealing novel insights into the pathogenesis of age-related cataracts. This work establishes the functional and molecular hallmarks of ferroptosis in aged ocular tissue and provides a framework for targeted oxidative stress assays in aging research.
-
Amyloid Beta-peptide (25-35): Applied Workflows in Neurotoxi
2026-04-27
Amyloid Beta-peptide (25-35) (human) empowers researchers to model Alzheimer’s-relevant neurotoxicity and microglial polarization with high fidelity. Discover protocol best practices, troubleshooting strategies, and the latest insights from translational systems biology to accelerate neurodegenerative disease research.
-
Cy3 NHS Ester (Non-Sulfonated): Practical Guide for Protein
2026-04-26
Cy3 NHS ester (non-sulfonated) enables sensitive, covalent fluorescent labeling of proteins, peptides, and oligonucleotides via primary amine groups. This guide details optimal handling, workflow integration, and troubleshooting for this orange-emitting dye, while clarifying its recommended scope and solubility boundaries.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Workflow Guidelines
2026-04-25
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific immunofluorescence detection of goat IgG in various immunodetection assays, including ICC/IF, IHC, flow cytometry, and ELISA. It should be used strictly within validated workflows for goat antibody detection and is not suited for applications outside these contexts.
-
Estradiol Benzoate: Next-Generation Precision in Estrogen Re
2026-04-24
Discover how Estradiol Benzoate, a synthetic estrogen receptor alpha agonist, is enabling advanced, reproducible estrogen receptor signaling research. Explore a deeper, protocol-driven perspective linking molecular mechanisms to practical assay optimization.
-
Cy3 NHS ester (non-sulfonated): Practical Guide for Biomolec
2026-04-24
Cy3 NHS ester (non-sulfonated) provides a robust solution for fluorescent labeling of proteins, peptides, and oligonucleotides via amino group conjugation. It is best suited for workflows that tolerate organic co-solvents and require orange fluorescence (Ex 555 nm, Em 570 nm). This dye is not optimal for applications demanding strict aqueous conditions or those sensitive to organic solvents.
-
Fenipentol in Gastrointestinal Physiology Studies: Protocols
2026-04-23
Fenipentol (1-Phenylpentan-1-ol) is revolutionizing gastrointestinal and hepatobiliary research through its precise modulation of secretion pathways and estrogen receptor signaling. Leveraging robust experimental workflows and network pharmacology, researchers can unlock new frontiers in digestive and cardiovascular physiology with validated, reproducible results.
-
Elbasvir–Grazoprevir Combination: Efficacy in HCV Genotype 1
2026-04-23
The referenced review systematically evaluates the pharmacology, efficacy, and safety of the Elbasvir–Grazoprevir (EBR/GZR) fixed-dose combination for hepatitis C virus (HCV) infections, with a focus on genotypes 1 and 4. Key innovations include robust sustained virologic response rates across diverse patient populations and a high barrier to resistance, supporting its use in complex clinical settings.
-
PDI Inhibition Enhances Panobinostat Activity in Multiple My
2026-04-22
This study demonstrates that co-inhibition of protein disulfide isomerase (PDI) with LTI6426 significantly boosts the anti-myeloma efficacy of panobinostat at low, less toxic doses in preclinical models. By converging on ER stress pathways, this combination may offer a safer, more effective therapeutic strategy and identifies new pharmacodynamic biomarkers for treatment response.
-
Bestatin (Ubenimex): Precision Inhibition in Cancer Research
2026-04-22
Bestatin (Ubenimex) stands out for its selective aminopeptidase inhibition, enabling high-specificity dissection of cancer and multidrug resistance mechanisms. Its proven performance in apoptosis and angiogenesis assays empowers advanced experimental workflows for oncology labs.